What is variceal bleeding in a patient with liver cirrhosis and portal hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Variceal Bleeding?

Variceal bleeding is hemorrhage from enlarged submucosal veins (varices) that develop in the esophagus or stomach as a direct consequence of portal hypertension in patients with liver cirrhosis, representing one of the most dangerous and life-threatening complications of advanced liver disease. 1

Pathophysiology and Development

Portal hypertension drives variceal formation through a specific mechanism:

  • Increased intrahepatic vascular resistance from cirrhosis elevates portal pressure above 5 mm Hg, defining portal hypertension 2
  • When hepatic venous pressure gradient (HVPG) reaches ≥10 mm Hg (clinically significant portal hypertension), collateral vessels begin forming at sites where portal and systemic circulation communicate 1, 2
  • Varices develop as these collaterals enlarge, with approximately 50% of cirrhotic patients having varices at diagnosis 1
  • Bleeding occurs when HVPG exceeds 12 mm Hg—below this threshold, variceal hemorrhage does not occur 1

Types and Classification

Varices are classified by anatomic location:

  • Esophageal varices (EVs): Most common type, graded as small (<5 mm) or large (≥5 mm) 1
  • Gastroesophageal varices (GOV): Extensions of esophageal varices into the stomach, subdivided into GOV1 (along lesser curvature, 74% of cases) and GOV2 (extending to fundus) 1
  • Isolated gastric varices (IGV): Occur without esophageal varices, classified as IGV1 (fundal) or IGV2 (body, antrum, pylorus) 1

Clinical Significance and Mortality

Variceal bleeding carries substantial morbidity and mortality:

  • Occurs in approximately 12% of cirrhotic patients with varices per year (5% for small varices, 15% for large varices) 1
  • Despite modern therapy, 6-week mortality remains 12-22% 1
  • Bleeding stops spontaneously in only 40% of cases 1
  • Without treatment, rebleeding occurs in 60% of patients within 1 year 1, 3
  • Gastric varices bleed less frequently (25% at 2 years) but cause more severe hemorrhage with higher mortality than esophageal varices 1

Risk Factors for Bleeding

Three critical factors predict variceal hemorrhage:

  • Variceal size: Larger varices have dramatically higher bleeding risk 1, 4
  • Red color signs: Red wale marks (longitudinal dilated venules) or red spots on variceal surface indicate imminent rupture risk, with 80% of patients with these findings experiencing bleeding 1, 4
  • Severity of liver disease: Child-Pugh class B/C and decompensated cirrhosis significantly increase bleeding risk 1, 4

Hemodynamic Predictors

Portal pressure measurements provide prognostic information:

  • HVPG >20 mm Hg measured within 24 hours of bleeding predicts failure to control hemorrhage (83% vs 29%) and 1-year mortality (64% vs 20%) compared to lower pressures 1
  • HVPG ≥16 mm Hg is strongly associated with death 2

Common Pitfall to Avoid

Do not confuse portal hypertensive gastropathy with variceal bleeding—portal hypertensive gastropathy causes a snake-skin or mosaic mucosal pattern on endoscopy and typically presents with chronic bleeding and anemia rather than acute massive hemorrhage, requiring different management strategies focused on portal pressure reduction rather than endoscopic variceal therapy 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Portal Hypertension in Cirrhosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Variceal and other portal hypertension related bleeding.

Best practice & research. Clinical gastroenterology, 2013

Guideline

Management of Esophageal Varices with Red Color Signs

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the management approach for a patient with a history of liver disease, such as cirrhosis, and esophageal varices classified using the Dor classification?
Why is ceftriaxone (a third-generation cephalosporin antibiotic) given to patients with variceal bleeding in the digestive tract, likely due to underlying liver cirrhosis?
What causes variceal bleeding and its management?
What is the role of hemodialysis in patients with liver cirrhosis?
What pharmacological intervention is recommended for a cirrhotic patient with portal hypertension and upper GI bleeding due to varices after initial resuscitation?
Can weight loss be further reduced in a patient with obesity and possibly type 2 diabetes by using Inositol and Glucagon-like peptide-1 (GLP-1) agonists, such as liraglutide (GLP-1 agonist) or semaglutide (GLP-1 agonist), compared to using GLP-1 agonists alone?
What is a suitable Selective Serotonin Reuptake Inhibitor (SSRI) for a female patient in her late 50s with no specified past medical history?
What is the best next step for a patient with a history of pancreatitis and impaired glucose control (A1c 7.8) who is already on Sodium-Glucose Cotransporter 2 (SGLT2) inhibitors, insulin degludec, and metformin?
What is the effect of N-acetylcysteine (NAC) on a 6.5 week escitalopram (selective serotonin reuptake inhibitor (SSRI)) treated patient with obsessive-compulsive disorder (OCD)?
What cough medication can a patient allergic to guaifenesin (expectorant) use?
Is it safe to add propranolol (10mg twice daily as needed) to the medication regimen of an elderly patient with dementia, who is experiencing daily panic attacks and is currently taking lexapro (escitalopram) 5mg daily, abilify (aripiprazole) 10mg daily, depakote (valproate) 500mg with dinner, trazodone 100mg at bedtime as needed, sinemet, and lisinopril for blood pressure management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.